NCT03997175 (ImmunoG1) is a NA clinical trial of Biodiversity powder in Atopic Disorders, sponsored by University of Helsinki.

Who is sponsoring NCT03997175?

NCT03997175 is sponsored by University of Helsinki.

What drugs are being tested in NCT03997175?

Interventions in NCT03997175: Biodiversity powder, Placebo.

What condition does NCT03997175 study?

NCT03997175 studies Atopic Disorders, Immune System Diseases.

Is NCT03997175 still recruiting?

NCT03997175 is currently completed. Last updated 25 June 2019.

Last reviewed 2019-06-25 · How we verify

NCT03997175: ImmunoG1

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effect of Modified Playground Environment on Health, Particularly Immune System

Completed NA Last updated 25 June 2019

What this trial tests

NA trial testing Biodiversity powder in Atopic Disorders in 25 participants. Completed in 30 July 2018.

Timeline

15 April 2018

Primary endpoint
30 July 2018

30 July 2018

Quick facts

Lead sponsor	University of Helsinki
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	quadruple
Primary purpose	basic science
Enrollment	25
Start date	15 April 2018
Primary completion	30 July 2018
Estimated completion	30 July 2018
Sites	1 location across Finland

Drugs / interventions tested

Biodiversity powder
Placebo

Conditions studied

Atopic Disorders — all drugs for Atopic Disorders →
Immune System Diseases — all drugs for Immune System Diseases →

Sponsor

University of Helsinki

Who can join

Adults 3 to 5, any sex, with Atopic Disorders or Immune System Diseases. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Children were exposed to biodiverse material or non-diverse material in sand pits. The two arms were compared. Immune response and bacterial markers were followed.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Atopic Disorders

Currently open trials in the same condition.

NCT05334940 — Atopy Network - Comprehensive Allergy Centers: Medical Care of Patients With Moderate to Severe Allergic Diseases · recruiting

Other University of Helsinki trials

Trials by the same sponsor.

NCT07212361 — Infant Microbiota Restoration With Maternal Microbes · NA · recruiting
NCT06799988 — NutFinForce: The Impact of Digitally Delivered Lifestyle Performance Medicine Intervention on Defense Performance in Fin · not yet recruiting
NCT06464003 — Orthodontic Screening in Public Healthcare · recruiting
NCT06092372 — The Role of Genetics in Weight Loss · NA · completed
NCT06564675 — Accuracy of EEG Slow Wave Activity in Predicting Favourable Outcome in Patients With Hypoxic Brain Injury - A Substudy o · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03997175 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Helsinki
Last refreshed: 25 June 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03997175.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing